BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32078861)

  • 1. Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets.
    Hou X; Sun JP; Ge L; Liang X; Li K; Zhang Y; Fang H
    Eur J Med Chem; 2020 Mar; 190():112131. PubMed ID: 32078861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Robust High-Throughput Screening Platform for Inhibitors of the Striatal-Enriched Tyrosine Phosphatase (STEP).
    Lambert LJ; Grotegut S; Celeridad M; Gosalia P; Backer LJ; Bobkov AA; Salaniwal S; Chung TD; Zeng FY; Pass I; Lombroso PJ; Cosford ND; Tautz L
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule.
    Tautermann CS; Binder F; Büttner FH; Eickmeier C; Fiegen D; Gross U; Grundl MA; Heilker R; Hobson S; Hoerer S; Luippold A; Mack V; Montel F; Peters S; Bhattacharya S; Vaidehi N; Schnapp G; Thamm S; Zeeb M
    J Med Chem; 2019 Jan; 62(1):306-316. PubMed ID: 30207464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer's disease.
    Xu J; Chatterjee M; Baguley TD; Brouillette J; Kurup P; Ghosh D; Kanyo J; Zhang Y; Seyb K; Ononenyi C; Foscue E; Anderson GM; Gresack J; Cuny GD; Glicksman MA; Greengard P; Lam TT; Tautz L; Nairn AC; Ellman JA; Lombroso PJ
    PLoS Biol; 2014 Aug; 12(8):e1001923. PubMed ID: 25093460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Checking the STEP-Associated Trafficking and Internalization of Glutamate Receptors for Reduced Cognitive Deficits: A Machine Learning Approach-Based Cheminformatics Study and Its Application for Drug Repurposing.
    Jamal S; Goyal S; Shanker A; Grover A
    PLoS One; 2015; 10(6):e0129370. PubMed ID: 26066505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of ERK dephosphorylation by striatal-enriched protein tyrosine phosphatase.
    Li R; Xie DD; Dong JH; Li H; Li KS; Su J; Chen LZ; Xu YF; Wang HM; Gong Z; Cui GY; Yu X; Wang K; Yao W; Xin T; Li MY; Xiao KH; An XF; Huo Y; Xu ZG; Sun JP; Pang Q
    J Neurochem; 2014 Jan; 128(2):315-329. PubMed ID: 24117863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives.
    Li Y; Lu L; Zhu M; Wang Q; Yuan C; Xing S; Fu X; Mei Y
    Biometals; 2011 Dec; 24(6):993-1004. PubMed ID: 21618062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors.
    Witten MR; Wissler L; Snow M; Geschwindner S; Read JA; Brandon NJ; Nairn AC; Lombroso PJ; Käck H; Ellman JA
    J Med Chem; 2017 Nov; 60(22):9299-9319. PubMed ID: 29116812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Glycols Discover Cryptic Pockets on Proteins for Fragment-Based Approaches.
    Bansia H; Mahanta P; Yennawar NH; Ramakumar S
    J Chem Inf Model; 2021 Mar; 61(3):1322-1333. PubMed ID: 33570386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized allosteric inhibition of engineered protein tyrosine phosphatases with an expanded palette of biarsenical small molecules.
    Korntner S; Pomorski A; Krężel A; Bishop AC
    Bioorg Med Chem; 2018 May; 26(9):2610-2620. PubMed ID: 29673715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptic Pockets Repository through Pocket Dynamics Tracking and Metadynamics on Essential Dynamics Space: Applications to Mcl-1.
    Benabderrahmane M; Bureau R; Voisin-Chiret AS; Santos JSO
    J Chem Inf Model; 2021 Nov; 61(11):5581-5588. PubMed ID: 34748701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
    Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X
    J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CryptoSite: Expanding the Druggable Proteome by Characterization and Prediction of Cryptic Binding Sites.
    Cimermancic P; Weinkam P; Rettenmaier TJ; Bichmann L; Keedy DA; Woldeyes RA; Schneidman-Duhovny D; Demerdash ON; Mitchell JC; Wells JA; Fraser JS; Sali A
    J Mol Biol; 2016 Feb; 428(4):709-719. PubMed ID: 26854760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase.
    Baguley TD; Xu HC; Chatterjee M; Nairn AC; Lombroso PJ; Ellman JA
    J Med Chem; 2013 Oct; 56(19):7636-50. PubMed ID: 24083656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators.
    Hart KM; Moeder KE; Ho CMW; Zimmerman MI; Frederick TE; Bowman GR
    PLoS One; 2017; 12(6):e0178678. PubMed ID: 28570708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Conformational Landscapes and Cryptic Binding Pockets in Distinct Functional States of the SARS-CoV-2 Omicron BA.1 and BA.2 Trimers: Mutation-Induced Modulation of Protein Dynamics and Network-Guided Prediction of Variant-Specific Allosteric Binding Sites.
    Verkhivker G; Alshahrani M; Gupta G
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cosolvent-Enhanced Sampling and Unbiased Identification of Cryptic Pockets Suitable for Structure-Based Drug Design.
    Schmidt D; Boehm M; McClendon CL; Torella R; Gohlke H
    J Chem Theory Comput; 2019 May; 15(5):3331-3343. PubMed ID: 30998331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel phosphatase inhibitor may be a STEP toward ameliorating cognitive dysfunction.
    Robinson R
    PLoS Biol; 2014 Aug; 12(8):e1001924. PubMed ID: 25093574
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery of a cryptic pocket in the AI-predicted structure of PPM1D phosphatase explains the binding site and potency of its allosteric inhibitors.
    Meller A; De Oliveira S; Davtyan A; Abramyan T; Bowman GR; van den Bedem H
    Front Mol Biosci; 2023; 10():1171143. PubMed ID: 37143823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal-enriched Tyrosine Protein Phosphatase (STEP) in the Mechanisms of Depressive Disorders.
    Kulikova E; Kulikov A
    Curr Protein Pept Sci; 2017 Aug; 18(11):1152-1162. PubMed ID: 28699511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.